General Counsel
Mon, Mar 14, 2022
Mar 14
exercised or converted securities in TXMD
230,000 shares @ $0.00
Decreased holdings by -100.00%
Net across this filing: +795.60% (+230,000 shares)
TXMDTherapeuticsMD, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W+2.49%
1M0.00%
3M-2.37%
6M—
1Y—